Disability from endometriosis in the United States Army

R O Boling, Boling RO, R Abbasi, Abbasi R, Rashmeena Abbasi, Gary E. Ackerman, Ackerman G, G. Ackerman, Arthur H. Schipul, A H Schipul, Schipul AH Jr, Chaney SA, S A Chaney, Sarah Chaney
The Journal of reproductive medicine · 1988 · vol. 33(1) , pp. 49–52 · PMID:2965241 · W9674580
Observational OA: closed CC0 ⤵ 32 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This study reviewed US Army women's records, finding a 6.2% endometriosis prevalence and an average of 15 sick days per admission, resulting in over 21,000 lost duty days in five years.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The impact of endometriosis on the general population has been well documented, and the prevalence rate is quoted as 10%. The records of 6,456 women in the United States Army were reviewed with respect to age, race and active duty status. The active duty records were further evaluated for total sick days from endometriosis-related problems. This evaluation revealed a mean sick time of 15 days per admission per active-duty patient regardless of age or race. The estimate of lost duty time was 21,746 days, considering all active-duty patients in the study (five years of records). The prevalence of endometriosis in the female U.S. Army population was 6.2%. Diagnosis and treatment of endometriosis should be aggressively pursued whenever the disease is suspected.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Military Personnel Military Personnel Adolescent Adolescent Adult Adult Endometriosis Endometriosis Endometriosis Female Female Humans Humans Middle Aged Middle Aged Persons with Disabilities Persons with Disabilities Retrospective Studies Retrospective Studies

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (14)

Cited by (30)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:21:50.425981+00:00
License: CC0 · commercial use OK